Randomised Evaluation of Sodium Dialysate Levels on Vascular Events
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 50000 participants.
Also called NCT02823821
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose health services research
- Phase
- Phase 4
- Enrolled
- 50,000 participants
- Sponsor
- Registry
-
NCT02823821
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Australia, Canada, Germany, India, Malaysia, United Kingdom
- Registry status
- Recruiting
Technical summary
Registry record NCT02823821. Randomized; no masking; primary purpose health services research. Start 2016-06 (actual); primary completion 2026-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Randomised Evaluation of Sodium Dialysate Levels on Vascular Events
- Acronym
- RESOLVE
- Condition
- End-Stage Kidney Disease
- Intervention (Other)
- Default dialysate sodium concentration of 137mmol/l
- Intervention (Other)
- Default dialysate sodium concentration of 140mmol/l
- Lead sponsor
- University of Sydney
- Collaborator
- Australasian Kidney Trials Network
- Collaborator
- Australia & New Zealand Dialysis & Transplant Registry
- Collaborator
- The George Institute
- Collaborator
- The George Institute for Global Health, China
- Collaborator
- Peking University People's Hospital
- Collaborator
- Institute for Clinical Evaluative Sciences
- Collaborator
- St. Michaels Hospital
- Collaborator
- Wuerzburg University Hospital
- Collaborator
- Malaysian Society of Nephrology
- Collaborator
- Malaysian Renal Registry
- Collaborator
- University College, London
Record details
- Record id
cardio:ct-nct02823821- Content hash
265b053bc8f7a9d16cbebd8bc31b1408567b8fcc193bfaa52d6f7fa0b9fbde2f